{"id":"NCT04733157","sponsor":"University of Zimbabwe","briefTitle":"The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section","officialTitle":"The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-03-23","primaryCompletion":"2021-12-14","completion":"2021-12-14","firstPosted":"2021-02-01","resultsPosted":"2023-03-20","lastUpdate":"2023-03-20"},"enrollment":1226,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Postpartum Hemorrhage"],"interventions":[{"type":"DRUG","name":"Tranexamic acid injection","otherNames":["TXA"]},{"type":"OTHER","name":"Normal saline placebo","otherNames":[]}],"arms":[{"label":"Study group/Group A","type":"EXPERIMENTAL"},{"label":"Control group/Group B","type":"PLACEBO_COMPARATOR"}],"summary":"This study seeks to determine if the using tranexamic acid prophylactically at caesarean section will prevent postpartum haemorrhage which is a major cause of maternal mortality in Zimbabwe and globally.","primaryOutcome":{"measure":"Number of Participants With Postpartum Hemorrhage (PPH)","timeFrame":"Up to day 2 postpartum","effectByArm":[{"arm":"Study Group/Group A_(Tranexamic Acid)","deltaMin":409,"sd":null},{"arm":"Control Group/Group B_(Placebo)","deltaMin":399,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.33"}]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":13},"locations":{"siteCount":2,"countries":["Zimbabwe"]},"refs":{"pmids":["37106343"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":611},"commonTop":["Vomiting","Dizziness","Nausea"]}}